Clinical trials
Phase 2 Recurrence trials in Israel
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 2 |
| 2009 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2020 | 3 |
| 2022 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Active, not recruiting | 3 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 3 |
| AstraZeneca | 2 |
| Cellectar Biosciences, Inc. | 1 |
| CureTech Ltd | 1 |
| Eisai Inc. | 1 |
| Eli Lilly and Company | 1 |
| Genmab | 1 |
| Geron Corporation | 1 |
| MedImmune LLC | 1 |
| Meirav Kedmi MD | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 16 |
| Lymphoma, Large B-Cell, Diffuse | 5 |
| Lymphoma, Non-Hodgkin | 4 |
| Neoplasms | 4 |
| Head and Neck Neoplasms | 2 |
| Leukemia | 2 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Multiple Myeloma | 2 |
| Blood Protein Disorders | 1 |
| Breast Neoplasms | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.